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acidified with concentrated HCl. The resulting mixture was diluted with benzene (125 mL), TsOH (100 mg) was added, and the solution was heated for 7 h at reflux in a flask affixed with a Dean-Stark trap. The solution was cooled to room temperature, concentrated, diluted with CHCl 3 (150 mL), and washed with sat NaHCO 3 (3 x 50 mL) and sat NaCl (50 mL). The organic layer was dried over sodium sulfate and concentrated to provide an orange solid (1.583 g, 86%) : mp 258-259 ˚C (lit. mp 257 ˚C).
1 H NMR (CDCl 3 , 400 MHz) δ 8.40 (d, 1 H), 8.32 (d, 1 H), 7.84-7.79 (m, 1 H), 7.61-7.39 (m, 5 H) .
ESI-MS (m/z) [M+H]
+ 249.02.
Compound 6
Histamine was added to a stirred solution of benz[d]-indeno [1,2-b] pyran-5,11-dione (0.5 g, 2.0 mmol) in chloroform (50 mL), and the reaction mixture was stirred at room temperature for 12 hrs. The reddish brown precipitate was dissolved in chloroform (150 mL), and 2 M HCl in ether (10.0 mL, 20.0 mmol) was added slowly to the reaction mixture, which was then stirred at room temperature for 5 hrs. The product was filtered, washed with chloroform (50 mL) and dried to obtain pure indenoisoquinoline 6 (0.65 g, 82%) as a red solid. Characterization of 6: 1 H NMR (DMSO-d6, 400 MHz) δ 8.99 (1H), 8.55, (d, 1H), 8.22 (s, 1H), 8.10 (d, 2H), 7.80 (m, 2H), 7.57-7.58 (m, 4H) , 4.78 (t, 2H), 3.20 (t, 2H) . 13 C NMR (DMSO-d6, 400 MHz) δ 190. 724, 163.068, 156.838, 137.034, 134.956, 134.814, 134.647, 134.587, 132.499, 131.983, 130.209, 129.574, 128.762, 127.852, 124.287, 123.436, 117.589, 107.892, 43.517, Scheme S1. Synthetic scheme for the preparation of acetal G.
Synthesis of B:
Methyl 4-(bromomethyl)-3-methoxy benzoate (A) (1.50 mg, 5.79 mmol) was dissolved in 20 mL DMF, along with potassium acetate (682 mg, 6.95 mmol). The reaction was heated to 60°C for 2.5 h. The DMF was removed by rotary evaporation and the residue was dissolved in methylene chloride. 
Synthesis of D:
Compound C (1.5 g, 7.6 mmol) was dissolved in dry dichloromethane, and manganese dioxide (13.3 g, 153 mmol) was added. The reaction was stirred under nitrogen at room temperature for 5 hrs, then filtered to remove the solids. The dichloromethane was removed under reduced pressure, and the reaction was purified via silica chromatography using a 80:20 ratio of hexanes and ethyl acetate. 
Synthesis of E:
Compound D (1.165 g, 6.0 mmol) was refluxed under nitrogen for 3 hrs in absolute ethanol with triethyl orthoformate (2.93 g, 19.8 mmol) and p-TsOH (10 mg).
Then, the ethanol was removed under reduced pressure, and the reaction was purified by silica chromatography using a 80:15:5 mixture of hexanes, ethyl acetate, and triethylamine, to give the product as a clear and colorless oil in 99% yield. 
Synthesis of I:
Hexaethylene glycol (H) (25 g, 88.5 mmol) was dissolved in anhydrous DCM and the reaction was cooled to 0°C using an ice bath. Tosyl chloride (33.7 g, 177 mmol) was added, and crushed KOH (39.7 g, 708 mmol) was added in small amounts, keeping the temperature below 5°C. The reaction was stirred for 3 h at 0°C, then purified by extraction with H 2 O and DCM. The DCM layers were combined and dried over Na 2 SO 4 , and the product was obtained (51.12 g, 86.5 mmol) in 98% yield. Characterization of I: 
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Synthesis of J:
Compound I (50 g, 84.6 mmol) was dissolved in anhydrous DMF, and sodium azide (22 g, 338 mmol) was added. The reaction was stirred at 80°C for 18 h. Then, the solvent was evaporated, and diethyl ether was added. The solids were filtered and washed, and the ether was evaporated to produce the product (27.55 g, 82.9 mmol) in 98% yield. Characterization of J:
Synthesis of K:
Compound J (25 g, 75.2 mmol) was dissolved in THF, and triphenylphosphine (79 g, 301 mmol) and 20 mL of H 2 O were added. The reaction was allowed to stir at room temperature, overnight. The solid residue was extracted with EtOAc, and the product was purified by column chromatography using an eluent of 80:10:10 DCM:MeOH:Et 3 N to afford the product in 50% yield. 
Synthesis of M:
Folic acid (L) (1.0 g, 2.26 mmol) was dissolved in dimethylformamide, and dicyclohexylcarbodiimide (DCC) (0.46 g, 2.26 mmol) and N-hydroxysuccinimide (NHS) (0.26 g, 2.26 mmol) were added. The reaction was stirred for 10 hrs in the dark, at room S10 temperature. Then, the folic acid-NHS ester was precipitated using diethyl ether, filtered, and used in the next step without further purification.
Synthesis of N (same as compound 8):
Compound N was prepared according to a previously published procedure for the preparation of a similar folate conjugate. 2 The product M from the previous step was dissolved in pyridine, and the hexaethylenediamine K was added. The reaction was stirred under room temperature for 12 hrs, in the dark. Afterwards, the pyridine was removed by rotary evaporation, and the product was purified by DEAE Sephacel anion exchange column (GE Healthcare). The product consisted mainly of a mixture of α and ϒ-carboxyl linked isomers of the product, which was separated based on the different pK a s of the underivatized carboxyl groups on the folate conjugates (pKa = 2.5 for a free α-carboxyl and pKa = 4.5 for a free ϒ-carboxyl). After loading onto a DEAE Sephacel column, the product was eluted by using a gradient of ammonium bicarbonate from 50 to 200 mmol/L. The PEGylated isomers of folic acid were identified by their characteristic absorption spectrums. The peaks corresponding to the ϒ-linked folic acid were pooled and lyophilized. To avoid degradation, the product was protected from light by using aluminum foil and stored in a -20 C freezer. 
Synthesis of O:
Compound G (1.0 g, 3.7 mmol) was dried on a vacuum pump overnight prior to use. Then, anhydrous thionyl chloride (0.09 g, 0.75 mmol) and freshly distilled acetyl chloride (0.47 g, 6.0 mmol) were added, and the reaction was stirred, neat, at 70°C for 90 min. Excess thionyl chloride and acetyl chloride were removed in vacuo, and the product was used for the next step without any further purification. To characterize compound O, a crude 1 H NMR of the was obtained, and a characteristic shift of the acetal peak from 5.5 ppm to 6.6 ppm was observed, indicating the formation of the chloro hemi-acetal.
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Synthesis of P:
Compound 6 (1.0 g, 2.9 mmol) was dissolved in anhydrous DMSO, and NaH (0.077 g, 3.2 mmol) was added. The reaction was allowed to stir for 30 min under N 2 at room temperature, and then carefully transferred into a flask containing compound O using a cannula. The reaction was then allowed to stir overnight, and the organic solvent was evaporated as much as possible. The product was taken to the next step without further purification.
Synthesis of Q (same as compound 7)
Compound P was dissolved in THF, and 
Synthesis of DDS 9:
Indenoisoquinoline-NEBI L (0.2 g, 0.34 mmol) was dissolved in 1 mL of anhydrous DMSO, and HATU (0.155 g, 0.41 mmol) and DIPEA (50 µL) was added. The reaction was stirred for 30 min, and the folate conjugate K, which was also dissolved in a S13 small amount of anhydrous DMSO was added to the reaction. The reaction was placed in a microwave reactor for 3 hrs at 65°C. The product, DDS 9, was purified using a Hitachi L-2130 HPLC system with a RediSep Rf Gold® high performance C18 column (Teledyne Isco), using a gradient of 15%-50% ACN in H 2 O over 30 minutes, with a flow rate of 2 mL/min. The DDS 9 was obtained in 10% purified yield. Characterization of (9) 
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Synthesis of R:
Indenoisoquinoline 6 (0.5 g, 1.46 mmol) was dissolved in anhydrous DMSO and sodium hydride (0.042 g, 1.76 mmol) was added. The reaction was stirred for 30 min before methyl bromoacetate (0.27 g, 1.76 mmol) was added. After stirring for 2 hrs under N 2 at room temperature, the organic solvent was evaporated as much as possible, and the product was taken to the next step without further purification.
Synthesis of S:
Compound R was dissolved in THF, and LiOH in H 2 O was added. The reaction was stirred for 18 hrs at 45°C, then extracted with DCM and NH 4 Cl. The DCM layers were combined and dried over Na 2 SO 4 . The product was purified further by column chromatography using DCM, MeOH, and Et 3 N in a 90:5:5 ratio, to obtain compound S as an orange solid in 65% overall yield over two steps. Characterization of S: 1 
Synthesis of Compound 10:
Compound S (0.2 g, 0.5 mmol) was dissolved in 1 mL of anhydrous DMSO, and HATU (0.23 g, 0.6 mmol) and DIPEA (50 µL) was added. The reaction was stirred for 30 min, and the folate conjugate N, which was also dissolved in a small amount of anhydrous DMSO was added to the reaction. The reaction was placed in a microwave reactor for 3 hrs at 65°C. The product, compound 10, was purified using a Hitachi L-2130 HPLC system with a RediSep Rf Gold® high performance C18 column (Teledyne Isco), using a gradient of 15%-50% ACN in H 2 O over 30 minutes, with a flow rate of 2 mL/min. Compound 10 was obtained in 10% purified yield. Characterization of (10) 
Hydrolysis studies of the folate-conjugated DDS 9
The hydrolysis of the DDS 9 was monitored by reverse-phase high performance liquid chromatography (RP-HPLC) with an Agilient 1100 Series HPLC using an analytical reverse-phase column (SPHERI-5 Phenyl 5 micron, 250 x 4.6 mm). The compound was dissolved in 0.3 mL of 18.6 mM MES buffer (pH 5.5) or 18.6 mM HEPES buffer (pH 7.4), containing 30% v/v DMSO, and incubated at 37°C. Small aliquots (15 µL) of the solutions were injected at regular time intervals, and products were eluted with a flow rate of 1 mL/min using an isocratic solvent mixture of 70% MeOH and 30% H 2 O, with 0.1% TFA. The chromatograms were analyzed at λ= 460 nm, and the retention rates of compound 6 and DDS 9 were 3.5 min and 7.5 min, respectively. The rates of hydrolysis of the DDS 9 was determined by calculation of the relative integrated HPLC peak areas of the compound 6 and DDS 9 at 460nm at each time point.
Cytotoxicity assays
In vitro cytotoxicity of the FR-targeted DDS was evaluated using a modified pulse-chase SRB assay. 
Folate competition assays
Competition assays were performed using the same in vitro pulse-chase SRB cytotoxicity assay described above. First, KB cells were plated onto a fibronectin-treated 96 well plate at 3000 cells/well in regular Roswell Park Memorial Institute (RPMI) 1640 medium (Invitrogen) which contains 0.001 g/L folic acid (2.2 µM). The cells were incubated for 24 hrs under a humidified atmosphere of 95% air and 5% CO 2 at 37°C.
After 24 hrs of incubation, the cells were dosed with various concentrations of DDS 9, in triplicates. The cells were incubated with the compounds for 5 hrs, and then washed to remove unbound compound. After washing, the cells were incubated for another 67 hrs in fresh RPMI 1640 medium. The cells were then fixed and stained with SRB, following the same procedures as described above.
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In a second folate competition assay, KB cells were dosed with 80 µM of DDS 9 using RPMI 1640 media containing increasing concentrations of folate (from 2.2 µM to 1 mM). The cells were incubated with DDS 9 for 5 hrs, and then washed to remove unbound compound. After washing, the cells were incubated for an additional 67 hrs in RPMI medium containing the same amounts of folate, but without DDS 9. Nitrocellulose blot. KB cells were selected for the studies reported here since these cells appeared to exhibit the largest natural expression of FR among all of the cells tested.
Procedure for cell lysis
Cell dishes were placed on ice, and the cells were washed 3 times with ice cold PBS. Then, 0.5 mL of Novex Tricine SDS sample buffer (2x) (Invitrogen) and 0.5 mL of DI H 2 O were added, and the cells were scraped off the bottom of the plate using a prechilled cell scraper. The extracts were heated in boiling water for 5 minutes, and then sonicated for 3-4 bursts of 5-10 seconds each. The cell extracts were then spun down at 12,000 rpm for 20 min. The supernatant was removed and filtered over a 0.45 µm filter, and used directly for loading onto the SDS PAGE gel.
Procedure for SDS PAGE gel
Samples were prepared in Novex Tricine SDS sample buffer (2x) (Invitrogen) and deionized H 2 O (see previous procedure for cell lysis). Fifteen microliters of each sample was loaded into each lane of a NuPAGE Novex 12% Bis-Tris gel (Invitrogen Life Technologies). The gel was run under 150 V for 60 minutes, in duplicate. One copy of the gel was stained with 0.1% Coomassie blue in 50% methanol, 10% acetic acid, and destained with 50% methanol and 10% acetic acid. The second gel was used for a western blot using nitrocellulose membrane.
Procedure for western blot
The SDS PAGE gel was transferred to a 0.45 mm nitrocellulose membrane (Invitrogen Life Technologies) using a XCell II blot module (Invitrogen) over 2 hours at 25 V. After the transfer, the nitrocellulose membrane was blocked with 5% BSA for 1 hour at room temperature. The nitrocellulose membrane was carefully cut along the S23 horizontal line at approximately the level of 45 kDa. The top portion of the membrane was incubated overnight at 4°C with a 1:500 dilution of 1 mg/mL rabbit anti-beta tubulin (Sigma Aldrich), which was used as a loading control. Beta tubulin has a molecular weight of approximately 55 kDa. The bottom portion of the membrane was incubated overnight at 4°C with a 1:500 dilution of 1 mg/mL rabbit Anti-FOLR1 (Sigma Aldrich).
FOLR1 has a molecular weight of approximately 34 kDa. All dilutions were made with TBST buffer. The next day, the blot was washed 5 times with TBST and incubated with a 1:10,000 dilution of the secondary antibody (1 mg/mL mouse monoclonal anti-rabbit IgG, Sigma Aldrich) for 1 hr at room temperature, shielded from light. The blot was then washed 5 more times with TBST and imaged using a Bio-rad molecular imager gel doc system. 
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